Document detail
ID

doi:10.1186/s12866-022-02739-z...

Author
Liu, Jilai Qin, Xuejun Lin, Boxi Cui, Jing Liao, Juan Zhang, Fu Lin, Qing
Langue
en
Editor

BioMed Central

Category

Mycology

Year

2022

listing date

3/8/2023

Keywords
hashimoto’s thyroiditis gut microbiota 16s rdna high-throughput sequencing biomarkers studies hca gut microbiota ht
Metrics

Abstract

Background Hashimoto’s thyroiditis (HT) is an autoimmune disease.

Recent studies have found that the gut microbiota may play an important role in inducing HT, but there are no systematic studies on the changes in the gut microbiota during the development of HT.

Methods In this study, 16S rDNA high-throughput sequencing technology in combination with the Kruskal–Wallis test, CCA/RDA analysis, Spearman correlation analysis, and other statistical methods were used to analyze the effects of age, gender, hormones, and other environmental factors on gut microbiota by comparing the differences in the microbiota at different stages of HT development.

Results The results showed that there were differences in the gut microbiota composition between healthy people (HCA) and in patients with HT.

Lachnoclostridium , Bilophila, and Klebsiella were enriched in the HCA group, while Akkermansia , Lachnospiraceae , Bifidobacterium , Shuttleia, and Clostriworthdia were enriched in the HT group.

Environmental factors analysis revealed that the Bifidobacterium and Klebsiella were two groups of bacteria that have undergone dramatic changes in HCA and HT, and mainly affected by gender.

Romboutsia and Haemophilus regulated by the hormone of free triiodothyronine (FT3) may promote the development of HT, while Faecalibacterium and Lachnospiraceae regulated by free thyroxine (FT4) may protect the host.

Conclusions Comprehensive studies have shown that gender is an important factor affecting gut microbial composition, but with the development of HT, hormones, age, and TSH begin to become dominant factors.

Liu, Jilai,Qin, Xuejun,Lin, Boxi,Cui, Jing,Liao, Juan,Zhang, Fu,Lin, Qing, 2022, Analysis of gut microbiota diversity in Hashimoto’s thyroiditis patients, BioMed Central

Document

Open

Share

Source

Articles recommended by ES/IODE AI

Systematic druggable genome-wide Mendelian randomization identifies therapeutic targets for lung cancer
agphd1 subtypes replication hykk squamous cell gene carcinoma causal targets mendelian randomization cancer analysis